Skip to main content

and
  1. No Access

    Article

    Dabrafenib Therapy in 30 Patients with Melanoma Metastatic to the Brain: a Single-centre Controlled Retrospective Study in Hungary

    Dabrafenib is a potent BRAF inhibitor, which showed intracranial tumor activity. The purpose of our retrospective analysis was to evaluate the efficacy of dabrafenib for patients with melanoma brain metastasis...

    Eszter Gorka, Dániel Fabó, András Gézsi, Kata Czirbesz in Pathology & Oncology Research (2018)